Ticker
XOMACompany Name
XOMA ROYALTY CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | Enterprise Value | Enterprise Value over EBITDA |
---|---|---|---|
6/30/2025 | $ -2.98M | $ 412.83M | 0 |
3/31/2025 | $ 3.33M | $ 351.75M | 105.72 |
12/31/2024 | $ -10.84M | $ 264.53M | 0 |
9/30/2024 | $ -20.03M | $ 332.65M | 0 |
6/30/2024 | $ -10.2M | $ 287.72M | 0 |
3/31/2024 | $ -34.73M | $ 260.38M | 0 |
12/31/2023 | $ -39.24M | $ 258.27M | 0 |
9/30/2023 | $ -25.78M | $ 153.32M | 0 |
6/30/2023 | $ -24.65M | $ 148.12M | 0 |
3/31/2023 | $ -24.15M | $ 165.62M | 0 |
EV / EBITDA
(=) EV/EBITDA
EV/EBITDA for XOMA ROYALTY CORP is calculated as follows: EV [ $ 275.66M ] / EBITDA [ $ -10.95M ]
(=) EV/EBITDA [ 0 ]
Minimum
Mar 31, 2022
Maximum
Mar 31, 2025
Average
Median
filtered constituents | 2.44K |
---|---|
min | 0.01 |
max | 40.82 |
average | 13.48 |
median | 11.75 |
std | 7.65 |